Skip to main content
. 2022 Jul 18;10:911551. doi: 10.3389/fpubh.2022.911551

Figure 1.

Figure 1

IP-10 levels in serum. (A) Baseline levels of serum IP-10 in HCV-infected patients were higher than that in healthy controls (p < 0.001), but there was no statistical difference between PR and DAAs treatment group; (B) There was no statistical difference in serum IP-10 levels between different subgroups divided according to ALT levels, although higher than that in healthy controls (p < 0.001). (C) There was no statistical difference in serum IP-10 levels between different subgroups divided according to HCV RNA loads, although higher than that in healthy controls (p < 0.001). (D) Regardless of HAI score >4 or ≤ 4, serum IP-10 levels were both significantly higher than that in healthy controls (p < 0.001), and it was higher in the group of HAI score >4 patients than that in ≤ 4 patients (p < 0.05).